Speaker illustration

Doctor Tobias Daniel Trippel

Charite University Hospital, Berlin (Germany)

A double-blind, randomised, two arm parallel group trial to determine the effects of torasemide versus furosemide on one marker (PIP) of cardiac fibrosis in patient with HFpEF and T2DM

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Diuretics

Session: Chronic heart failure

Thumbnail

Gender specific treatment effects of Spironolactone in Diastolic Heart Failure: Insight from ALDO-DHF

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb